1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Companies

  • All
    • Pfizer Inc.
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • October 2019
  • 206 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Pfizer Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Lymphoma Treatment Drugs Companies in China

  • $ 1800
  • October 2019
  • 71 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.

Lymphoma Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • October 2019
  • 84 pages

LYMPHOMA TREATMENT DRUGS PRODUCTION AND I.

  • Pharmaceutical
  • China
  • Demand
  • Trade
  • Pfizer Inc.

Vaginal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 381 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Sexually Transmitted Disease
  • United States
  • Pfizer Inc.

NHL: Mantle cell lymphoma

  • $ 5000
  • April 2016
  • 214 pages

Lymphoma Association (2016) Mantle cell lymphoma.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Pfizer Inc.

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 212 pages

BAY-##, AN ORAL ATR INHIBITOR, IS BEING INVESTIGATED IN A PHASE I STUDY (BAYER, NCT##) IN SOLID TUMORS (INCLUDING PCA) AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Prostate Cancer
  • Therapy
  • Pfizer Inc.

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029

  • $ 10995
  • June 2020
  • 129 pages

AMYLOIDOSIS MAY APPEAR IN CONJUNCTION WITH OR AS A RESULT OF THE FOLLOWING DISORDERS: MULTIPLE MYELOMA, HODGKIN' S LYMPHOMA, LYMPHOMA, MEDULLARY CARCINOMA OF THE THYROID, WHIPPLE DISEASE, CROHN' S DISEASE, OSTEOMYELITIS, RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, REITER NATIONAL

  • Antimalarials
  • Endocrine Disease
  • Lymphoma
  • Pathology
  • Pfizer Inc.

Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Route of Administration ; Application ; End User, and Geography

  • $ 4550
  • May 2020
  • 197 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced nonsmall cell lung cancer (NSCLC).

  • Lymphoma
  • Pharmaceutical
  • Forecast
  • Market Size
  • Pfizer Inc.

Global Auto-Injectors Market (By Application/Indication, Product Type, Usability, Distribution Channels, Region), Key Company Profiles - Forecast to 2025

  • $ 1990
  • August 2019
  • 126 pages

lymphoma, OCREVUS for the treatment of primary progressive MS (PPMS) and relapsing MS (RMS) and other potential anti-CD## therapies pursuant to its collaboration arrangements with Genentech, Inc.

  • Injectable Delivery
  • Lymphoma
  • World
  • Amgen Inc.
  • Pfizer Inc.

Global Chemotherapy Drugs Market - Opportunities and Forecast (2013-2023)

  • $ 2200
  • March 2019
  • 200 pages

Lymphoma Gastrointestine Others Figure ##: Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% Source: U. S Clinical Trials Registry GLOBAL THERAPEUTIC CHEMOTHERAPY DRUGS MARKET FIGURE ##: GLOBAL

  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
  • Pfizer Inc.

Vaginal Cancer - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 351 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • United States
  • Pfizer Inc.

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 403 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 228 pages

So the CAR T, for example, represents a cure of lymphoma and leukemia.

  • Blood Disease
  • Lymphoma
  • Pathology
  • Therapy
  • Pfizer Inc.

Nanopharmaceuticals - Thematic Research

  • $ 1950
  • March 2020
  • 96 pages

RAKUTEN MEDICAL IS HEADQUARTERED IN SAN DIEGO, CALIFORNIA, US. © GlobalData Abbreviations European Medicines Agency distearoylphosphatidylcholine dimethyl hydrazide diabetic macular edema diffuse large B-cell lymphoma cardiovascular Cutaneous T-cell lymphoma Complete Response Letter central

  • Lymphoma
  • Therapy
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • November 2018
  • 108 pages

This box warning has not been removed by the FDA or by the European Agency [despite evidence against the link between TCIs and lymphoma]. "

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Therapy
  • Pfizer Inc.

Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)

  • $ 900
  • September 2019
  • 77 pages

On July ##, 2019, the US Food and Drug Administration (FDA) approved RUXIENCE, a biosimilar to Rituxan to treat the adult patients with lymphoma, leukemia and polyangiitis.

  • Lymphoma
  • Oncology
  • Therapy
  • Amgen Inc.
  • Pfizer Inc.

Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2029

  • $ 10995
  • June 2020
  • 139 pages

LYMPHOMAS GO-2032C GSK-## CHIMERIX INC EXCELLTHERA INC FUJIFILM HOLDINGS CORP FUJIFILM HOLDINGS CORP AVEO ONCOLOGY INC MACROGENICS INC SYNIMMUNE GMBH CHONGQING PRECISION BIOTECH CO LTD PERSONGEN BIOMEDICINE SUZHOU CO LTD PERSONGEN BIOMEDICINE SUZHOU CO LTD GENUS ONCOLOGY LLC GLAXOSMITH

  • Chemotherapy
  • Leukemia
  • Lymphoma
  • Therapy
  • Pfizer Inc.

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • December 2018
  • 106 pages

FURTHERMORE, PSORIASIS IS COMMONLY ASSOCIATED WITH NAIL DISEASE, CARDIOVASCULAR DISEASE (CVD), LYMPHOMA, AND INFLAMMATORY BOWEL DISEASE (IBD) (MENTER ET AL., 2009).

  • Dermatological Condition
  • Lymphoma
  • Pathology
  • Therapy
  • Pfizer Inc.

Potential Pipeline Disruptors

  • $ 4200
  • May 2017
  • 120 pages

FOLLICULAR LYMPHOMA TENDS TO BE INDOLENT AND DIFFUSE LYMPHOMA TENDS TO BE AGGRESSIVE.

  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Pfizer Inc.

Global CML Market Report - 2022

  • $ 3849
  • June 2018
  • 82 pages

Imatinib mesylate is licensed as a firstline treatment for adults with chronic-phase Ph+ CML, and for the management of GIST, and as salvage therapy for Ph+ acute lymphoblastic lymphoma.

  • Lymphoma
  • Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Pfizer Inc.
View report >

Medical Biotechnology Industry in the US - Forecast

  • June 2017
  • 15 pages

Gazyva (Obinutuzumab) Roche 2015 sales: $## million 2022 sales: $##. ## billion CLL; follicular lymphoma ##.

  • Lymphoma
  • Medical Biotechnology
  • United States
  • Pfizer Inc.
  • Roche Group

Therapy Market in the US November 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on